Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing.
Health Care Economics and Organizations
MEDICATION SYSTEMS, HOSPITAL
PHARMACY SERVICE, HOSPITAL
Practice Guideline
Quality Assurance, Health Care
Quality of Health Care
Safety
Journal
European journal of hospital pharmacy : science and practice
ISSN: 2047-9956
Titre abrégé: Eur J Hosp Pharm
Pays: England
ID NLM: 101578294
Informations de publication
Date de publication:
22 Feb 2024
22 Feb 2024
Historique:
received:
02
05
2022
accepted:
26
09
2022
medline:
26
2
2024
pubmed:
15
10
2022
entrez:
14
10
2022
Statut:
epublish
Résumé
Pharmacy and therapeutics committees (PTCs) are multidisciplinary hospital teams responsible for rational medication use. We aimed at developing and piloting an assessment tool for their operating quality.We conducted a scoping literature review in PubMed and Embase to identify potential assessment items. Their relevance was systematically rated and consolidated into the final tool.60 relevant items were included, grouped into eight focus topics: the committee's institutional integration, member characteristics, performance indicators, meeting structure, formulary decision-making and characteristics, strategies to guide medication use and medication use evaluations.In combination with a SWOT (strengths, weaknesses, opportunities and threats) analysis, the tool helped the identification of improvement opportunities for a pilot hospital: adapting the committee's structure, improving the formulary decision-making, implementing strategies to guide formulary medication use and strengthening the committee's recognition within the institution.The tool successfully identified improvement opportunities for a PTC and could therefore be interesting for other hospitals.
Identifiants
pubmed: 36241377
pii: ejhpharm-2022-003365
doi: 10.1136/ejhpharm-2022-003365
pmc: PMC10895181
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
171-174Informations de copyright
© European Association of Hospital Pharmacists 2024. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Basic Clin Pharmacol Toxicol. 2014 Sep;115(3):268-76
pubmed: 24528496
Eur J Clin Pharmacol. 2013 May;69 Suppl 1:79-87
pubmed: 23640192
Hosp Pharm. 2013 Jul;48(7):568-73
pubmed: 24421522
Br J Clin Pharmacol. 1998 Apr;45(4):393-8
pubmed: 9578188
Pharm World Sci. 1999 Apr;21(2):74-9
pubmed: 10380234
Eur J Clin Pharmacol. 2006 Jan;62(1):57-63
pubmed: 16372173
Am J Health Syst Pharm. 2008 Jul 1;65(13):1272-83
pubmed: 18589893
Am J Health Syst Pharm. 2015 Mar 1;72(5):408-13
pubmed: 25694416
Am J Health Syst Pharm. 2017 Sep 1;74(17):1336-1352
pubmed: 28743758
Expert Rev Clin Pharmacol. 2018 Dec;11(12):1255-1262
pubmed: 30451035